Fragile X Syndrome:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Fragile X Syndrome Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Fragile X Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Fragile X Syndrome 23
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Fragile X Syndrome Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Seaside Therapeutics, LLC 31
Clinical Trial Overview of Seaside Therapeutics, LLC 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Novartis Pharmaceuticals Corporation 34
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 34
Hoffmann-La Roche Inc. 35
Clinical Trial Overview of Hoffmann-La Roche Inc. 35
Autism Therapeutics LLC 36
Clinical Trial Overview of Autism Therapeutics LLC 36
Marinus Pharmaceuticals, Inc. 37
Clinical Trial Overview of Marinus Pharmaceuticals, Inc. 37
Neuropharm Group Plc (Inactive) 38
Clinical Trial Overview of Neuropharm Group Plc (Inactive) 38
Cortex Pharmaceuticals, Inc. 39
Clinical Trial Overview of Cortex Pharmaceuticals, Inc. 39
Neuren Pharmaceuticals Limited 40
Clinical Trial Overview of Neuren Pharmaceuticals Limited 40
Clinical Trial Overview of Top Institutes / Government 41
University of California, Davis 41
Clinical Trial Overview of University of California, Davis 41
Stanford University 42
Clinical Trial Overview of Stanford University 42
Indiana University 43
Clinical Trial Overview of Indiana University 43
Parc de Salut Mar 44
Clinical Trial Overview of Parc de Salut Mar 44
The Mediterranean Institute for the Advance of Biotechnology and Health Research 45
Clinical Trial Overview of The Mediterranean Institute for the Advance of Biotechnology and Health Research 45
FRAXA Research Foundation 46
Clinical Trial Overview of FRAXA Research Foundation 46
Catharina Ziekenhuis 47
Clinical Trial Overview of Catharina Ziekenhuis 47
National Health Research Institutes 48
Clinical Trial Overview of National Health Research Institutes 48
Cincinnati Children’s Hospital Medical Center 49
Clinical Trial Overview of Cincinnati Children’s Hospital Medical Center 49
National Institute of Mental Health 50
Clinical Trial Overview of National Institute of Mental Health 50
Eunice Kennedy Shriver National Institute of Child Health and Human Development 51
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 51
The University of North Carolina 52
Clinical Trial Overview of The University of North Carolina 52
Rush University Medical Center 53
Clinical Trial Overview of Rush University Medical Center 53
Indiana University School of Medicine 54
Clinical Trial Overview of Indiana University School of Medicine 54
All India Institute of Medical Sciences 55
Clinical Trial Overview of All India Institute of Medical Sciences 55
Massachusetts General Hospital 56
Clinical Trial Overview of Massachusetts General Hospital 56
Rabin Medical Center 57
Clinical Trial Overview of Rabin Medical Center 57
Five Key Clinical Profiles 58
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84


【レポート販売概要】

■ タイトル:Fragile X Syndrome:グローバル臨床試験レビューH2, 2013
■ 英文:Fragile X Syndrome Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月5日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162038
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。